Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Te Ling

Showing results (91-100 of 116) with videos related to

Pageof 12
Sort By:
Cancer Medicine|November 30, 2018
Clinical significance of glutamate metabotropic receptors in renal cell carcinoma risk and survivalChao-Yuan Huang, Yu-Mei Hsueh, Lih-Chyang Chen, et al.
American Journal of Cancer Research|June 7, 2021
Association between the polygenic liabilities for prostate cancer and breast cancer with biochemical recurrence after radical prostatectomy for localized prostate cancerShi-Heng Wang, Shu-Pin Huang, Yi-Jiun Pan, et al.
Cancer Medicine|April 18, 2019
Effect of genetic variants in cell adhesion pathways on the biochemical recurrence in prostate cancer patients with radical prostatectomyChia-Cheng Yu, Lih-Chyang Chen, Victor C Lin, et al.
Cancer Cell International|May 6, 2022
TNFRSF13B is a potential contributor to prostate cancerChia-Yang Li, Shu-Pin Huang, Yei-Tsung Chen, et al.
International Journal of Molecular Sciences|December 6, 2016
Prognostic Relevance of Methylenetetrahydrofolate Reductase Polymorphisms for Prostate CancerVictor C Lin, Te-Ling Lu, Hsin-Ling Yin, et al.
American Journal of Physiology. Renal Physiology|April 11, 2019
MST3 is involved in ENaC-mediated hypertensionTe-Jung Lu, Wei-Chih Kan, Sung-Sen Yang, et al.
International Journal of Cancer|March 30, 2011
Significant associations of prostate cancer susceptibility variants with survival in patients treated with androgen-deprivation therapyBo-Ying Bao, Jiunn-Bey Pao, Chun-Nung Huang, et al.
World Journal of Urology|December 24, 2011
Vitamin D receptor gene variants and clinical outcomes after androgen-deprivation therapy for prostate cancerJiunn-Bey Pao, Ying-Pi Yang, Chun-Nung Huang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 11, 2009
Prognostic significance of prostate cancer susceptibility variants on prostate-specific antigen recurrence after radical prostatectomyShu-Pin Huang, Li-Chia Huang, Wen-Chien Ting, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|May 2, 2026
Fourteen-day vonoprazan-based dual therapy with amoxicillin as first-line Helicobacter pylori treatment in comparison with sequential therapy: A randomized controlled trialTe-Ling Ma, Chun-Ying Huang, Chen-Ya Kuo, et al.
Pageof 12

Showing results (91-100 of 116) with videos related to

Sort By:
Pageof 12
Cancer Medicine|November 30, 2018
Clinical significance of glutamate metabotropic receptors in renal cell carcinoma risk and survivalChao-Yuan Huang, Yu-Mei Hsueh, Lih-Chyang Chen, et al.
American Journal of Cancer Research|June 7, 2021
Association between the polygenic liabilities for prostate cancer and breast cancer with biochemical recurrence after radical prostatectomy for localized prostate cancerShi-Heng Wang, Shu-Pin Huang, Yi-Jiun Pan, et al.
Cancer Medicine|April 18, 2019
Effect of genetic variants in cell adhesion pathways on the biochemical recurrence in prostate cancer patients with radical prostatectomyChia-Cheng Yu, Lih-Chyang Chen, Victor C Lin, et al.
Cancer Cell International|May 6, 2022
TNFRSF13B is a potential contributor to prostate cancerChia-Yang Li, Shu-Pin Huang, Yei-Tsung Chen, et al.
International Journal of Molecular Sciences|December 6, 2016
Prognostic Relevance of Methylenetetrahydrofolate Reductase Polymorphisms for Prostate CancerVictor C Lin, Te-Ling Lu, Hsin-Ling Yin, et al.
American Journal of Physiology. Renal Physiology|April 11, 2019
MST3 is involved in ENaC-mediated hypertensionTe-Jung Lu, Wei-Chih Kan, Sung-Sen Yang, et al.
International Journal of Cancer|March 30, 2011
Significant associations of prostate cancer susceptibility variants with survival in patients treated with androgen-deprivation therapyBo-Ying Bao, Jiunn-Bey Pao, Chun-Nung Huang, et al.
World Journal of Urology|December 24, 2011
Vitamin D receptor gene variants and clinical outcomes after androgen-deprivation therapy for prostate cancerJiunn-Bey Pao, Ying-Pi Yang, Chun-Nung Huang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 11, 2009
Prognostic significance of prostate cancer susceptibility variants on prostate-specific antigen recurrence after radical prostatectomyShu-Pin Huang, Li-Chia Huang, Wen-Chien Ting, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|May 2, 2026
Fourteen-day vonoprazan-based dual therapy with amoxicillin as first-line Helicobacter pylori treatment in comparison with sequential therapy: A randomized controlled trialTe-Ling Ma, Chun-Ying Huang, Chen-Ya Kuo, et al.
Pageof 12